INTEGRA LIFESCIENCES HOLDINGS CORP

Integra LifeSciences manufactures and distributes surgical instruments and medical devices across three primary clinical areas: neurosurgery, otolaryngology, and wound care. The company's neurosurgery and neurocritical care portfolio includes tissue ablation equipment, dural repair products, cerebrospinal fluid management devices, intracranial monitoring equipment, and cranial stabilization systems. Its ENT business offers instrumentation, balloon dilation technologies for sinus and eustachian tube procedures, and surgical navigation systems. The wound care division serves plastic, reconstructive, and general surgeons with products for acute wound treatment, chronic wounds including diabetic foot ulcers, and tissue repair applications for hernia, tendon, and peripheral nerve repair.

The company operates through two segments: Codman Specialty Surgical and Tissue Technologies. Codman handles neurosurgery, neuro-critical care, and ENT products including surgical headlamps, instrumentation, and after-market services. Tissue Technologies focuses on wound care and surgical tissue repair products, including skin and wound repair materials, bone grafts, and nerve and tendon repair solutions.

Integra distributes its products through direct sales forces and other channels to hospitals, integrated health networks, group purchasing organizations, surgery centers, and dental, podiatry, and veterinary practices. The company maintains a geographic presence across the United States, Europe, Asia Pacific, and other international markets. Incorporated in Delaware in 1989, the company is headquartered in Princeton, New Jersey.